Autres langues vTv Therapeutics Inc.

Actions

VTVT

US9183852048

Temps Différé Nasdaq Autres places de cotation 18:37:56 07/05/2024			Varia. 5j.	Varia. 1 janv.
24,51 ^USD	-0,77%		-12,15%	+113,13%

14/03	VTv Therapeutics Inc. annonce des changements au sein de son conseil d'administration	CI
13/03	VTv Therapeutics Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

VTv Therapeutics : 2024 Notice of Annual Meeting and Proxy Statement	30/04
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT	19/03
VTv Therapeutics Inc. Announces Board Changes	14/03
VTv Therapeutics: Q4 Earnings Snapshot	13/03
VTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update	13/03
VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
VTv Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
VTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference	04/03
VTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes	04/03
VTv Therapeutics Inc. Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes	04/03
VTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference	01/03
Top Midday Gainers	28/02
VTv Therapeutics Inc. Announces Board Changes	28/02
VTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund	28/02
VTv Therapeutics Inc. announced that it has received $50.961457 million in funding from JDRF T1D Fund, Samsara BioCapital LLC and another investors	27/02
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE	22/02
Vtv Therapeutics Inc. Announces Resignation of Chandresh Harjivan as Member of the Board of Directors	22/12
VTv Therapeutics: Q3 Earnings Snapshot	09/11
VTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update	09/11
VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues vTv Therapeutics Inc.

Actions

VTVT

US9183852048

Autres langues

Filtres